Table 2.
Fragment size (kDa) | Fragment name | System | ||||
---|---|---|---|---|---|---|
4.2 PLL | 24 PLL | 4.2 PEG-PLL | 24 PEG-PLL | |||
Fibrinogen | 48 | γ | ∗∗∗ | ∗∗ | ∗∗ | ∗∗∗ |
56 | β | ∗∗∗ | ∗∗ | ∗∗∗ | ∗∗∗ | |
68 | α | ∗∗∗ | ∗∗∗ | ∗∗∗ | ∗∗∗ | |
<48 | Cleavage | ∗ | 0 | ∗ | ∗∗ | |
Albumin | 66 | ∗∗∗ | ∗∗∗ | ∗∗∗ | ∗∗∗ | |
C3 | 42 | Activation | ∗∗ | ∗ | ∗∗ | ∗∗ |
70 | β | ∗ | ∗∗ | ∗∗ | ∗∗ | |
115 | α | 0 | 0 | 0 | 0 | |
Apolipoprotein A-1 | 27 | 0+ | 0+ | 0 | 0 | |
Plasminogen | 25 | 0 | 0 | 0 | 0 | |
60 | 0+ | ∗ | 0 | 0 |
Plasma proteins eluted with 1.0 mL of 2% SDS in PBS; 0 indicates zero band intensity, while 0+ indicates trace band intensity and ∗∗∗indicates highest intensity bands. Proteins shown in Table 1 but absent from this table were not observed in immunoblotting (zero band intensity throughout).